Skip to main content
. 2016 Nov 25;8(2):3104–3110. doi: 10.18632/oncotarget.13621

Figure 3.

Figure 3

A. MTT assay showing knockdown of SPRY4-IT1 inhibited cell proliferation of NoZ cells compared to the negative control; B. MTT assay showingoverexpression of SPRY4-IT1 promoted cell proliferation of GBC-SD cells compared to the negative control.